Transjugular intrahepatic portosystemic shunt: Current status

Gastroenterology

Volumn 124, Issue 6, 2003, Pages 1700-1710

  Boyer, Thomas D ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCITES; BRAIN DISEASE; BUDD CHIARI SYNDROME; ESOPHAGUS VARICES BLEEDING; HEPATOPULMONARY SYNDROME; HEPATORENAL SYNDROME; HUMAN; HYDROTHORAX; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; REVIEW; SALVAGE THERAPY; SURVIVAL; VEIN OCCLUSION;

EID: 0038531139     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(03)00377-9     Document Type: Review

References (76)

1. Conn HO, Lindenmuth WW, May CJ, Ramsby GR. Prophylactic portacaval anastomosis. Medicine (Baltimore) 1972;51:27-40.
2. Boyer TD, Henderson JM. Portal hypertension and bleeding esophageal varices. In: Zakim D, Boyer TD, eds. Hepatology: a textbook of liver disease (4th ed). Philadelphia: Saunders, 2002:581-629.
3. Boyer TD. Pharmacologic treatment of portal hypertension: past, present and future. Hepatology 2001;34:834-839.
4. Luketic VA, Sanyal AJ. Esophageal varices. II. TIPS (transjugular intrahepatic portosystemic shunt) and surgical therapy. Gastroenterol Clin North Am 2000;29:387-421.
5. Rössle M, Richter GM, Noldge G, Palmaz JC, Wenz W, Gerok W. New non-operative treatment for variceal haemorrhage. Lancet 1989;2:153.
6. Rösch J, Hanafe W, Snow H, Barenfus M, Gray R. Transjugular intrahepatic portocaval shunt. Am J Surg 1971;121:588-592.
7. Rösch J. The creation of TIPS: a brief history. In: Conn HO, Palmaz JC, Rosch J, Rossle M, eds. TIPS: transjugular intrahepatic portosystemic shunts. New York: Igaku-Shoin, 1996:55-64.
8. Colapinto RF, Stronell RD, Birch SJ, Langer B, Blendis LM, Greig PD, Gilas T. Creation of an intrahepatic portosystemic shunt with a Gruntzig balloon catheter. Can Med Assoc J 1982;126:267-268.
9. Colapinto RF, Stronell RD, Gildiner M, Ritchie AC, Langer B, Taylor BR, Blendis LM. Formation of intrahepatic portosystemic shunts using a balloon dilatation catheter: preliminary clinical experience. AJR Am J Roentgenol 1983;140:709-714.
10. Zemel G, Katzen BT, Becker GJ, Benenati JF, Sallee DS. Percutaneous transjugular portosystemic shunt. JAMA 1991;266:390-393.
11. Rössle M, Haag K, Ochs A, Sellinger M, Noldge G, Perarner J-M, Berger E, Hauenstein K, Langer M, Gerok W. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994;330:165-171.
12. Martin M, Zajko AB, Orons PD, Dodd G, Wright H, Colangelo J, Tartar R. Transjugular intrahepatic portosystemic shunt in the management of variceal bleeding: indications and clinical results. Surgery 1993;114:719-26; discussion 726-727.
13. Ring EJ, Lake JR, Roberts JP, Gordon RL, LaBerge JM, Read AE, Sterneck MR, Ascher NL. Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation. Ann Intern Med 1992;116:304-309.
14. Burroughs AK, Patch D. Transjugular intrahepatic portosystemic shunt. Semin Liver Dis 1999;19:457-473.
15. Bureau C, Carlos J, Pagan G, Layrargues GP, Otal P, Chabbert V, Rangueil T, Cortez C, Perreault P, Peron JM, Gonzalez-Abraldes J, Bouchard L, Bilbao JI, Bosch J, Rousseau H, Rangueil T, Vinel JP, Purpan T. The use of polytetrafluoroethylene (PTFE) covered stents improves the patency of TIPS: results of a randomized study (abstr). Hepatology 2002;36:101A.
16. Rossle M, Siegersterrer V, Olschewski M, Ochs A, Berger E, Haag K. How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts. Am J Gastroenterol 2001;96:3379-3383.
17. Casado M, Bosch J, Garcia-Pagan JC, Bru C, Banares R, Bandi JC, Escorsell A, Rodrigues-Laiz J, Gilabert R, Feu F, Schorlemer C, Echenagusia A, Rodes J. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology 1998;114:1296-1303.
18. Feu F, Garcia-Pagan JC, Bosch J, Luca A, Teres J, Escorsella A, Rodes J. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995;346:1056-1059.
19. Boyer TD, Vargus EV. Transjugular intrahepatic portosystemic shunt, In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's diseases of the liver. (9th ed). Philadelphia: Lippincott Williams & Williams, 2003:369-382.
20. Jalan R, Elton RA, Redhead DN, Finlayson ND, Hayes PC. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol 1995;23:123-128.
21. Chalasani N, Clark WS, Martin LG, Kamean J, Khan A, Patel N, Boyer ID. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 2000;118:138-144.
22. Malinchoc M, Karnath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-871.
23. Patch D, Nikolopoulou V, McCormick A, Dick R, Amonis A, Wannamethee G, Burroughs A. Factors related to early mortality after transjugular intrahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding. J Hepatol 1998;28:454-460.
24. Brensing KA, Raab P, Textor J, Gorich J, Schiedermaier P, Strunk H, Paar D, Schepke M, Sudhop T, Spengler U, Schild H, Sauerbruch T. Prospective evaluation of a clinical score for 60-day mortality after transjugular intrahepatic portosystemic stentshunt. Eur J Gastroenterol Hepatol 2002;14:723-731.
25. LaBerge JM, Somberg KA, Lake JR, Gordon RL, Kerlan R, Ascher N, Roberts J, Simor M, Doherty C, Hahn J, et al. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology 1995;108:1143-1151.
26. Jalan R, Forrest EH, Stanley AJ, Redhead DN, Forbes J, Dillon SF, MacGilchrist A, Finlayson N, Hayes PC. A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology 1997;26:1115-1122.
27. LaBerge JM, Ferrell LD, Ring EJ, Gordon RL. Histopathologic study of stenotic and occluded transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 1993;4:779-786.
28. Saxon RR, Mendel-Hartvig J, Corless CL, Rabkin J, Uchida BT, Nishimine K, Keller F. Bile duct injury as a major cause of stenosis and occlusion in transjugular intrahepatic portosystemic shunts: comparative histopathologic analysis in humans and swine. J Vasc Interv Radiol 1996;7:487-497.
29. Sauer P, Theilmann L, Stremmel W, Benz C, Richter GM, Stiehl A. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. Gastroenterology 1997;113:1623-1631.
30. Canizares RB, Rodriguez-Laiz JM, Martin MC, Belda AE, Alonso F, Roldan F, Castro L, Arrequi E, Ricote G. Transjugular intrahepatic portosystemic shunt with the Strecker stent for control of refractory acute and chronic variceal bleeding. Scand J Gastroenterol 1996;31:285-293.
31. Sauer P, Theilmann L, Herrmann S, Bruckner T, Roeren T, Pichter G, Stremmel W, Stiehl A. Phenprocoumon for prevention of shunt occlusion after transjugular intrahepatic portosystemic stent shunt: a randomized trial. Hepatology 1996;24:1433-1436.
32. Rössle M, Siegerstetter V, Huber M, Ochs A. The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver 1998;18:73-89.
33. Sanyal AJ. The management of the cirrhotic patient after transjugular intrahepatic portosystemic shunt. Semin Gastrointest Dis 1997;8:188-199.
34. Jalan R, Lui HF, Redhead DN, Hayes PC. TIPSS 10 years on. Gut 2000;46:578-581.
35. Ducoin H, El-Khoury J, Rousseau H, Barange K, Peron J, Pierragi M, Rumeau J, Pascal J, Vinel J, Joffre F. Histopathologic analysis of transjugular intrahepatic portosystemic shunts. Hepatology 1997;25:1064-1069.
36. Sanyal AJ, Contos MJ, Yager D, Zhu YN, Willey A, Graham MF. Development of pseudointima and stenosis after transjugular intrahepatic portasystemic shunts: characterization of cell phenotype and function. Hepatology 1998;28:22-32.
37. Cabrera J, Maynar M, Granados R, Gorriz E, Reyes R, PulidoDuque J, San Roman J, Guerra C, Kravetz D. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 1996;110:832-839.
38. Cello JP, Ring EJ, Olcott EW, Koch J, Gordon R, Sandhu J, Morgan DR, Ostroff JW, Rochey D, Bacchetti P, LaBerge J, Lake JR, Somberg K, Doherty C, Davila M, McQuaid K, Wall SD. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial. Ann Intern Med 1997;126:858-865.
39. Sanyal AJ, Freedman AM, Luketic VA, Purdum P III, Shiffman M, Cole P, Tisnado J, Simmons S. Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial. Ann Intern Med 1997;126:849-857.
40. Merli M, Salerno F, Riggio O, de Franchis R, Fiaccadon F, Meddi P, Primignani M, Pedretti G, Maggi A, Capocaccia L, Lovaria A, Ugolotti U, Salvatori F, Bezzi M, Rossi P. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.). Hepatology 1998;27:48-53.
41. Garcia-Villarreal L, Martinez-Lagares F, Sierra A, Guevara C, Marrero J, Jimenez E, Monescillo A, Hemandez-Cabrero T, Alonso J, Fuentes R. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage. Hepatology 1999;29:27-32.
42. Sanyal AJ, Freedman AM, Luketic VA, Purdum P, Shiffman M, Tisnado J, Cole P. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology 1997;112:889-898.
43. Owens CA, Bartolone C, Warner DL, Aizenstein R, Hibblen J, Yaghmai B, Wiley T, Layden T. The inaccuracy of Duplex ultrasonography in predicting patency of transjugular intrahepatic portosystemic shunts. Gastroenterology 1998;114:975-980.
44. Rössle M. The implantation and maintenance of TIPS: rules of the road and tricks of the trade. In: Conn HO, Palmaz JC, Rosch J, Rossle M, eds. TIPS: transjugular intrahepatic portosystemic shunts. New York: Igaku-Shoin, 1996:177-198.
45. Pattynama PM, van Hoek B, Kool LJ. Inadvertent arteriovenous stenting during transjugular intrahepatic portosystemic shunt procedure and the importance of hepatic artery perfusion. Cardiovasc Intervent Radiol 1995;18:192-195.
46. Mallery S, Freeman ML, Peine CJ, Miller RP, Stanchfield WR. Biliary-shunt fistula following transjugular intrahepatic portosystemic shunt placement. Gastroenterology 1996;111:1353-1357.
47. Sanyal AJ, Freedman AM, Purdum PP, Shiffman ML, Luketic VA. The hematologic consequences of transjugular intrahepatic portosystemic shunts. Hepatology 1996;23:32-39.
48. Jalan R, Redhead DN, Allan PL, Hayes PC. Prospective evaluation of haematological alterations following the transjugular intrahepatic portosystemic stent-shunt (TIPSS). Eur J Gastroenterol Hepatol 1996;8:381-385.
49. Conn HO. Hemolysis after transjugular intrahepatic portosystemic shunting: the naked stent syndrome. Hepatology 1996;23:177-181.
50. Sanyal AJ, Reddy KR. Vegetative infection of transjugular intrahepatic portosystemic shunts. Gastroenterology 1998;115:110-115.
51. Sanyal AJ, Freedman AM, Shiffman ML, Purdum PP III, Luketic VA, Cheatham AK. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology 1994;20:46-55.
52. Somberg KA, Riegler JL, LaBerge JM, Doherty-Simor MM, Bachetti P, Roberts J, Lake JR. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors. Am J Gastroenterol 1995;90:549-555.
53. Azoulay D, Castaing D, Majno P, Saliba F, Ichai P, Small A, Delvart V, Danaoui M, Samuel D, Bismuth H. Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol 2001;35:590-597.
54. Papatheodoridis GV, Goulis J, Leandro G, Patch D, Burroughs AK. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a metaanalysis. Hepatology 1999;30:612-622.
55. Sauer P, Hansmann J, Richter GM, Stremmel W, Stiehl A. Endoscopic variceal ligation plus propranolol vs transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial. Endoscopy 2002;34:690-697.
56. Escorsell A, Banares R, Garcia-Pagan JC, Gilabert R, Moitinho E, Piqueras B, Bru C, Echenagusia A, Granados A, Bosch J. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology 2002;35:385-392.
57. Pomier-Layrargues G, Villeneuve JP, Deschenes M, Bui B, Perraeult P, Fenyves D, Willems B, Marleau D, Bilodeau M, Lafortune M, Dufresne MP. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial. Gut 2001;48:390-396.
58. Meddi P, Merli M, Lionetti R, DeSantis A, Valeriano V, Masini A, Rossi P, Salvaton F, Salemo F, de Franchis R, Capocuccia L, Riggio O. Cost analysis for the prevention of variceal rebleeding: a comparison between transjugular intrahepatic portosystemic shunt and endoscopic sclerotherapy in a selected group of Italian cirrhotic patients. Hepatology 1999;29:1074-1077.
59. Russo MW, Zacks SL, Sandler RS, Brown RS. Cost-effectiveness analysis of transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic therapy for the prevention of recurrent esophageal variceal bleeding. Hepatology 2000;31:358-363.
60. Rosemurgy AS, Serafini FM, Zweibel BR, Black TJ, Kudryk BT, Nord HJ, Goode SE. Transjugular intrahepatic portosystemic shunt vs. small-diameter prosthetic H-graft portacaval shunt: extended follow-up of an expanded randomized prospective trial. J Gastrointest Surg 2000;4:589-597.
61. Kamath PS, Lacerda M, Ahlquist DA, McKusick MA, Andrews JC, Nagorney DA. Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology 2000;118:905-911.
62. Chau TN, Patch D, Chan YW, Nagral A, Dick R, Burroughs AK. "Salvage" transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 1998;114:981-987.
63. Lebrec D, Giuily N, Hadengue A, Vilgrain V, Moreau R, Poynard T, Adrian G, Lassen C, Benhamou J-P, Erlinger S, a French Group of Clinicians and a Group of Biologists. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. J Hepatol 1996;25:135-144.
64. Rossle M, Ochs A, Gulberg V, Siegerstetter V, Holl J, Deibert P, Olschewski M, Reiser M, Gerbes AL. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000;342:1701-1707.
65. Gines P, Uriz J, Calaborra B, Garcia-Tsao G, Kamath PS, del Arbol LR, Planas R, Bosch J, Arroyo V, Rodes J. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002;123:1839-1847.
66. Sanyal A, Genning C, Reddy KR, Wong F, Kowdley KV, Benner K, McCashland T and the NASTRA group. The North American study for the treatment of refractory ascites. Gastroenterology 2003;124:634-641.
67. Strauss RM, Boyer TD. Hepatic hydrothorax. Semin Liver Dis 1997;17:227-232.
68. Strauss RM, Martin LG, Kaufman SL, Boyer TD. Transjugular intrahepatic portal systemic shunt (TIPS) for the management of symptomatic cirrhotic hydrothorax. Am J Gastroenterol 1994;89:1520-1522.
69. Gordon FD, Anastopoulos HT, Crenshaw W, Gilchrist B, McEniff N, Falchuk KR, LoCicero J III, Lewis WD, Jenkins RL, Trey C. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology 1997;25:1366-1369.
70. Siegerstetter V, Deibert P, Ochs A, Olschewski M, Blum HE, Rossle M. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol 2001;13:529-534.
71. Gines P, Arroyo V, Rodes J. Renal function in cirrhosis: pathophysiology and clinical features. In: Zakim D, Boyer TD, eds. Hepatology: a textbook of liver disease (4th ed). Philadelphia: Saunders, 2002:497-526.
72. Lake JR, Ring E, LaBerge J, Gordon R, Roberts J, Ascher N. Transjugular intrahepatic portacaval stent shunts in patients with renal insufficiency. Transplant Proc 1993;25:1766-1767.
73. Brensing KA, Textor J, Perz J, Schiedermaier P, Raab P, Strunk H, Klehr H, Kramer H, Spengler U, Schild H. Long term outcome after transjugular intrahepatic portosystemic stent-shunt in nontransplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 2000;47:288-295.
74. Wong F, Sniderman K, Liu P, Allidina Y, Sherman M, Blendis L. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Intern Med 1995;122:816-822.
75. Guevara M, Gines P, Bandi JC, Gilabert R, Sort P, Jimenez W, Garcia-Pagan JC, Bosch J, Arroyo V, Rodes J. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology 1998;28:416-422.
76. Angeli R, Volpin R, Gerunda G, Crighero R, Roner P, Merenda R, Amodio P, Sticca A, Caregaro L, Maffei-Faccioli A, Gatta A. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology 1999;29:1690-1697.